| Literature DB >> 10629367 |
F Shu1, M Sugimura, N Kanayama, H Kobayashi, T Kobayashi, T Terao.
Abstract
We investigated the clinical significance of annexin V in the placentae with preeclampsia and found: (1) annexin V was detected on trophoblasts in the placentae and the staining intensity of annexin V in the placentae from such patients was reduced when compared to normal placentae; (2) as expression of annexin V was reduced, the gestosis index from patients with preeclampsia was elevated and the standard deviation value in the infant's standard weight was decreased; plasma level of the fibrin degradation products and thrombin-antithrombin III complex from patients were elevated as the expression of anexin V was reduced. These results suggest that the reduced expression of annexin V in the placentae from patients with preeclampsia may lead to a hypercoagulable state in the intervillous space and may be associated with the development of intrauterine growth restriction. Copyright 2000 S. Karger AG, BaselEntities:
Mesh:
Substances:
Year: 2000 PMID: 10629367 DOI: 10.1159/000010206
Source DB: PubMed Journal: Gynecol Obstet Invest ISSN: 0378-7346 Impact factor: 2.031